BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6390258)

  • 21. The investigation of a heart valve patient with suspected hypercoagulability.
    Gough SC; Prentice CR
    J Heart Valve Dis; 1993 Jan; 2(1):7-17. PubMed ID: 8269113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?
    Yudkin JS
    Diabetes Care; 1999 Apr; 22 Suppl 3():C25-30. PubMed ID: 10189559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alterations of blood coagulation and endothelial function in diabetic microangiopathy].
    Porta M
    Minerva Med; 1980 Jan; 71(2):119-30. PubMed ID: 6986585
    [No Abstract]   [Full Text] [Related]  

  • 24. Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers.
    Soares AL; Sousa Mde O; Dusse LM; Fernandes AP; Lasmar MC; Novelli BA; Lages Gde F; Carvalho Md
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):395-9. PubMed ID: 17581312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma factors and platelet aggregation in diabetes mellitus.
    Colwell JA; Van Zile J; Kilpatrick JM; Nair RM; Virella G
    Horm Metab Res Suppl; 1981; 11():1-6. PubMed ID: 6976300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of rheological factors on diabetic microangiopathies: is there an effective medical treatment for diabetic retinopathy?].
    Meunier I; Soubrane G; Coscas G
    Bull Soc Belge Ophtalmol; 1995; 256():67-70. PubMed ID: 8581233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative and qualitative analysis of platelet GPIb and von Willebrand factor in liver cirrhosis.
    Beer JH; Clerici N; Baillod P; von Felten A; Schlappritzi E; Büchi L
    Thromb Haemost; 1995 Apr; 73(4):601-9. PubMed ID: 7495066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Data on thrombophilic states].
    Raffaello B; Bruno B
    Haematol Lat; 1969; 12(3):569-94. PubMed ID: 4919424
    [No Abstract]   [Full Text] [Related]  

  • 31. Treating diabetic retinopathy by tackling growth factor pathways.
    Chiarelli F; Giannini C; Di Marzio D; Mohn A
    Curr Opin Investig Drugs; 2005 Apr; 6(4):395-409. PubMed ID: 15898347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Occurrence of changes in the eye in diabetic retinopathy with significant myopia].
    Dujić M; Misailović K; Nikolić Lj; Ignjacev M
    Srp Arh Celok Lek; 1998; 126(11-12):457-60. PubMed ID: 9921019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemostasis and atherosclerosis.
    Warkentin TE
    Can J Cardiol; 1995 May; 11 Suppl C():29C-34C. PubMed ID: 7750046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in biochemical mechanisms of diabetic retinopathy.
    Giusti C; Gargiulo P
    Eur Rev Med Pharmacol Sci; 2007; 11(3):155-63. PubMed ID: 17970231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible involvement of Von Willebrand factor in pancreatic graft thrombosis after kidney-pancreas transplantation: a retrospective study.
    Kessler L; Wiesel ML; Boudjema K; Lutun E; Moulin B; Cazenave JP; Wolf P; Pinget M
    Clin Transplant; 1998 Feb; 12(1):35-42. PubMed ID: 9541421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological approach to diabetic retinopathy.
    De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS
    Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of coagulation function and fibrinolytic system assessment in patients with gestational diabetes mellitus].
    Liu BY; Jian YL; Zhong M; Yu YH; Wang Q; Zhang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):35-7. PubMed ID: 17259140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procoagulant albumin increases vascular endothelial cell prostacyclin secretion.
    Gubler DB; Ahlstrom CR; Liu L; Zhou JF; Parker CJ; Rodgers GM
    Thromb Haemost; 1995 Dec; 74(6):1573-7. PubMed ID: 8772239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.
    Kowluru RA; Menon B; Gierhart DL
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1645-51. PubMed ID: 18385086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic retinopathy: a preventable scourge.
    Jain S; Preetha K; Jain SC; Jain A
    J Indian Med Assoc; 2008 May; 106(5):303-4, 306. PubMed ID: 18839636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.